La. Drug Caps Conflict With Federal Law, AbbVie Says

By Jared Foretek · April 8, 2024, 8:31 PM EDT

Drugmaker AbbVie is asking a Louisiana federal judge to grant its summary judgment motion and block new state-level pharmaceutical caps for the federal 340B drug discount program, calling the state's competing...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

AbbVie Inc et al v. Landry

Case Number

Court

Louisiana Western

Nature of Suit

Constitutional - State Statute

Date Filed

September 21, 2023

Recent Articles By Jared

May 16, 2024
$5.5M Apotex Generic Drug Price-Fixing Deal Gets Initial OK
April 29, 2024
Judge Rejects Class Certification Of Seizure Drug Customers
March 04, 2024
Elanco Urges Justices To Preserve Junk Fax Win
March 01, 2024
Judge Says TCPA Class Limits Affect Only State Law Claims
January 19, 2024
JP Morgan, Others Must Face Sr. Care Investors' Claims
December 08, 2023
FCC Says Carriers Are Meeting On 988 Call Georouting Fixes
November 22, 2023
4th Circ. Upholds Subpoenas Over Md. Atty Extortion Case
November 21, 2023
PE Firm Faces 2nd Antitrust Suit Over Texas Anesthesia Biz
November 21, 2023
Baltimore Merck Vax Suit Proceeds But Utah, Idaho Claims Cut
October 19, 2023
5th Circ. Asks Illumina, FTC For Update On EU Order's Impact